Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Fingolimod for the Treatment of Intracerebral Hemorrhage: A 2-Arm Proof-of-Concept Study.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Oligoclonal band and multiple sclerosis risk in monosymptomatic optic neuritis patients: a retrospective study of 84 patients.
Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.
The microglial sensome revealed by direct RNA sequencing.
IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection.
Recent Gains in Clinical Multiple Sclerosis Research Review.
A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
The Symptom Inventory Disability-Specific Short Forms for Multiple Sclerosis: Reliability and Factor Structure.
Contribution of imaging to the diagnosis of optic neuropathies.
Novartis updates US label on Gilenya® following discussions with the FDA
Immunology: A tolerant approach.
Discovery of peptoid ligands for anti-aquaporin 4 antibodies.
Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy.

Pages